Pyxis Oncology (PYXS) Announces Appointment of Ken Kobayashi, M.D., F.A.C.P as Chief Medical Officer streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
William Blair restated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research note released on Wednesday morning, RTT News reports. Separately, Royal Bank of Canada started coverage on shares of Pyxis Oncology in a research note on Tuesday, September 5th. They issued an outperform rating and a $7.00 price […]
PYX-201 Phase 1 trial progressing with fifth dose cohort at 3.6 mg/kg; data expected 1H 2024. PYX-106 : Phase 1 trial now focusing on NSCLC and other tumor types; data expected 2H 2024. Cash runway.
Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.